Seeking Alpha

Bristol Myers (BMY -0.6%) is lower today after being cut to Market Perform at BMO Capital on the...

Bristol Myers (BMY -0.6%) is lower today after being cut to Market Perform at BMO Capital on the back of strong competitive Hep-C data from competitor Gilead (GILD +11.5%) and Merck's (MRK +0.3%) anti-PD-1 cancer immunotherpy results.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector